Next‐generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity

af Catenacci, Daniel V.T.
Udgivet i Mol Oncol (2014)

When Inhibitor MET Biomarker: Postmortem or Initium Novum?

af Catenacci, Daniel V.T.
Udgivet i JCO Precis Oncol (2019)

Next-Generation Companion Diagnostics: Promises, Challenges, and Solutions

af Khoury, Joseph D., Catenacci, Daniel V. T.
Udgivet i Arch Pathol Lab Med (2015)

Novel Targeted Therapies for Esophagogastric Cancer

af Maron, Steven B., Catenacci, Daniel V.T.
Udgivet i Surg Oncol Clin N Am (2017)

Update on Gastroesophageal Adenocarcinoma Targeted Therapies

af Maron, Steven B., Catenacci, Daniel V.T.
Udgivet i Hematol Oncol Clin North Am (2017)

A Subgroup Cluster-Based Bayesian Adaptive Design for Precision Medicine

af Guo, Wentian, Ji, Yuan, Catenacci, Daniel V. T.
Udgivet i Biometrics (2016)

Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma

af Joshi, Smita S, Maron, Steven B, Catenacci, Daniel V
Udgivet i Future Oncol (2018)

AAA: triple adaptive Bayesian designs for the identification of optimal dose combinations in dual-agent dose finding trials

af Lyu, Jiaying, Ji, Yuan, Zhao, Naiqing, Catenacci, Daniel V. T.
Udgivet i J R Stat Soc Ser C Appl Stat (2018)

The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now

af Rajagopal, Padma Sheila, Catenacci, Daniel V.T., Olopade, Olufunmilayo I.
Udgivet i J Clin Oncol (2019)

A Survey of the Population Genetic Variation in the Human Kinome

af Zhang, Wei, Catenacci, Daniel V.T., Duan, Shiwei, Ratain, Mark J.
Udgivet 2009

Personalized Colon Cancer Care in 2010

af Catenacci, Daniel V.T., Kozloff, Mark, Kindler, Hedy L., Polite, Blase
Udgivet 2011

Initial Report of Second‐Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi‐Institutional Retrospective Analysis

af Klempner, Samuel J., Maron, Steven B., Chase, Leah, Lomnicki, Samantha, Wainberg, Zev A., Catenacci, Daniel V.T.
Udgivet i Oncologist (2018)

Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound

af Catenacci, Daniel V. T., Chapman, Christopher G., Xu, Peng, Koons, Ann, Konda, Vani J., Siddiqui, Uzma D., Waxman, Irving
Udgivet i Gastroenterology (2015)

Obtaining Knowledge in Pathology Reports Through a Natural Language Processing Approach With Classification, Named-Entity Recognition, and Relation-Extraction Heuristics

af Oliwa, Tomasz, Maron, Steven B., Chase, Leah M., Lomnicki, Samantha, Catenacci, Daniel V.T., Furner, Brian, Volchenboum, Samuel L.
Udgivet i JCO Clin Cancer Inform (2019)

Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence

af Catenacci, Daniel V.T., Henderson, Les, Xiao, Shu-Yuan, Penuel, Elicia, Patel, Premal, Yauch, Robert L., Peterson, Amy, Salgia, Ravi
Udgivet 2011

Spatial and temporal heterogeneity of PD-L1 expression and tumor mutational burden (TMB) in gastroesophageal adenocarcinoma (GEA) at baseline diagnosis and after chemotherapy

af Zhou, Katherine I., Peterson, Bryan, Serritella, Anthony, Thomas, Joseph, Reizine, Natalie, Moya, Stephanie, Tan, Carol, Wang, Yan, Catenacci, Daniel V. T.
Udgivet i Clin Cancer Res (2020)

Therapeutically Induced Changes in HER2, HER3, and EGFR Protein Expression for Treatment Guidance

af Sellappan, Shankar, Blackler, Adele, Liao, Wei-Li, O’Day, Emily, Xu, Peng, Thyparambil, Sheeno, Cecchi, Fabiola, Hembrough, Todd, Catenacci, Daniel V.T.
Udgivet i J Natl Compr Canc Netw (2016)

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma

af Catenacci, Daniel V. T., Ang, Agnes, Liao, Wei‐Li, Shen, Jing, O'Day, Emily, Loberg, Robert D., Cecchi, Fabiola, Hembrough, Todd, Ruzzo, Annamaria, Graziano, Francesco
Udgivet i Cancer (2016)

Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1–Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti–PD-1 Monoclonal Antibody Therapy

af Reizine, Natalie, Peterson, Bryan, Moya, Stephanie, Wang, Yan, Tan, Yi-Hung Carol Y. H., Eng, Oliver S., Bilimoria, Malcolm, Lengyel, Ernst, Turaga, Kiran, Catenacci, Daniel V. T.
Udgivet i JCO Precis Oncol (2020)

Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma

af Catenacci, Daniel V.T., Rasco, Drew, Lee, Jeeyun, Rha, Sun Young, Lee, Keun-Wook, Bang, Yung Jue, Bendell, Johanna, Enzinger, Peter, Marina, Neyssa, Xiang, Hong, Deng, Wei, Powers, Janine, Wainberg, Zev A.
Udgivet i J Clin Oncol (2020)